Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
05/30/2024 01:47 AM
Pennsylvania House of Representatives
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search

House of Representatives
Session of 2019 - 2020 Regular Session


Posted: October 17, 2019 02:24 PM
From: Representative Christina D. Sappey
To: All House members
Subject: Warning Labels on Prescription Opioid Containers
While we have made progress in reducing the number of overdose deaths in Pennsylvania, this public health crisis is far from over. We must continue to implement commonsense solutions that will prevent future overdoses and instances of opioid addiction. That is why I will be introducing legislation requiring the State Board of Pharmacy to issue regulations requiring warning labels be added to opioid prescription bottles.

The addition of warning labels will ensure patients and their families across the Commonwealth are advised of the risks associated with prescription opioids every time they are used. In the United States, warning labels are already required on products, such as cigarettes and alcoholic beverages in order to inform the public about the health hazards that may result from their consumption or abuse. These labels have been shown to be an effective, low-cost method for communicating the product’s associated health risks. Warning labels on opioids would serve as a consistent reminder of the potential dangers of abusing prescription medication.

Please join me in supporting this important legislation.

Introduced as HB2092